For Varun Mohan, Insights Are Always Depreciating Every single insight we have is a depreciating insight.
Alteryx Thinks AI’s Future Depends on Analysts Not Engineers They’re the ones companies are going to turn to when it’s time to actually implement
Krea Valued at $500 Million After Funding from Bain and Andreessen Horowitz What Krea sells is control, control over what models are used, how outputs are shaped,
Charta Health Secures $8.1 Million After Turning Cold Emails Into Profit in Just 60 Days Charta Health’s core advantage is its ability to work within existing healthcare infrastructure rather than